GlycoBioSciences Inc.

News

01/26/2023

Andromaco to cease and desist, from any further sales or production of Hyalocare in Mexico.

06/14/2022

Glyco’s Canadian Patent 2,896,038, has been allowed

11/11/2021

Canadian Market Important Notice

04/03/2014

GlycoBioSciences Inc. Obtains FDA Clearance for 510 (k) K123193 for bio-fermented based IPM Wound Gel